AxoGen, Inc. (AXGN) NASDAQ
34.14
+0.5577(+1.66%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
34.14
+0.5577(+1.66%)
Currency In USD
| Previous Close | 33.58 |
| Open | 33.26 |
| Day High | 34.56 |
| Day Low | 33.08 |
| 52-Week High | 36 |
| 52-Week Low | 9.22 |
| Volume | 202,341.22 |
| Average Volume | 989,601 |
| Market Cap | 1.77B |
| PE | -100.4 |
| EPS | -0.34 |
| Moving Average 50 Days | 32.72 |
| Moving Average 200 Days | 23.1 |
| Change | 0.56 |
Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
GlobeNewswire Inc.
Feb 10, 2026 12:00 PM GMT
ALACHUA, Fla. and TAMPA, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will r
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
GlobeNewswire Inc.
Jan 22, 2026 4:18 AM GMT
ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced the pricing of
Axogen Announces Proposed Public Offering of Common Stock
GlobeNewswire Inc.
Jan 21, 2026 9:09 PM GMT
ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it intend